Driving Innovation

HAV logo

Publications

A Novel Multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis (2007).
Bull. TJ., Gilbert. SC., Sridhar.S., Linedale. R., Dierkes. N., Sidi-Boumedine. K., Hermon-Taylor. J. PLoS ONE 2(11): e1229.doi:10.1371/journal.pone.0001229
(http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001229#pone-0001229-g008)

Mycobacterium avium subspecies paratuberculosis, Crohn’s disease and the Doomsday scenario (2009). Hermon-Taylor. J. Gut Pathogens 1:15
(http://www.gutpathogens.com/content/1/1/15)

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A antigens (2014)
Antrobus. RD., Coughlan. L., Berthoud. TK., Dicks. MD., Hill. AVS., Lambe. T., Gilbert. SC. www.moleculartherapy.org 22:3; 668-674.
( http://www.nature.com/mt/journal/v22/n3/full/mt2013284a.html )

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge (7 Sept 2014). Stanley. DA., et al. Nature Medicine Online.
( http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.3702.html )